$DOCU

Marrs Anna sold $18K of DOCU

Marrs Anna sold 363 shares of DOCUSIGN, INC. (DOCU) at $49.42 on 2026-06-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Marrs Anna
Published Jun 5, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 9:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$DOCU
Neutral
medium confidence
Mentioned
$DOCU
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DOCUNeutralLow
01

Why it matters

The disclosure provides a datapoint on insider activity but does not indicate a new company event (no earnings, guidance, deal, or litigation).

02

Market read

Traders may briefly reassess sentiment around insider selling, but the 10b5-1 framing typically limits fundamental implications.

03

What to watch

Consider whether there were multiple insider transactions around the same period; a single Form 4 is less informative than a pattern.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed today (2026-06-05) after-hours

Background

This is an SEC Form 4 insider transaction disclosure for DOCUSIGN director Marrs Anna, executed as an open-market sale under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$DOCUNeutralMedium confidence
Context

Director Marrs Anna sold 363 DOCUSIGN shares in an open-market transaction under a pre-arranged Rule 10b5-1 plan.

Expected impact

Small, short-lived negative-to-neutral drift possible around disclosure; limited follow-through expected.

Evidence & confidence

The filing is a routine insider transaction and explicitly states a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

Minimal; single-company insider sale without new operational/regulatory developments.

None.

None.

Counterpoint

Because the sale is pre-arranged, the market may overreact; price impact could be negligible or even fade quickly.

Key entities

  • DOCUSIGN, INC.

    Subject of the Form 4 insider sale disclosure.

  • Marrs Anna

    Director who sold 363 shares at $49.42/share under a pre-arranged 10b5-1 plan.

Related articles

$LULUMed

Stock Market Today: Dow Futures Gain, S&P 500 Slips As Trump Floats Meeting Iran's Supreme Leader— Lulule

U.S. stock futures were mixed Friday: Nasdaq 100 and S&P 500 slipped while Dow futures rose after a mixed prior close. President Trump said he would consider meeting Iran’s Supreme Leader Ayatollah Mojtaba Khamenei if diplomacy progresses. Treasury yields were 4.46% (10-year) and 4.03% (2-year); FedWatch priced a 96.4% chance of no June rate change. Lululemon, Docusign (-4.73%), Samsara (-5.14%), and Keel (-8.94% on $350m convertibles) were among movers.

$LULUHighAI 9/10

Stocks making the biggest moves after hours: Lululemon Athletica, ServiceTitan, Argan and more

After-hours movers: Lululemon shares fell 10% after it cut full-year earnings and revenue guidance and its current-quarter outlook missed analyst expectations, per LSEG. Docusign slipped 4% as its Q2 revenue outlook ($865M–$869M) met but didn’t beat estimates. Guidewire dropped 16% on weaker adjusted gross margin. ServiceTitan rose 12% after raising full-year guidance.

$DOCUMedAI 9/10

DocuSign Delivers Beat-And-Raise Q1, But Investors Aren't Impressed - Docusign (NASDAQ:DOCU)

DocuSign reported Q1 revenue of $830.2 million, slightly above the $824.77 million consensus, and adjusted EPS of $1.09 versus $0.99 expected, according to Benzinga Pro. Revenue rose 9% YoY; free cash flow was $289.4 million. The company repurchased $317.5 million of stock and raised FY revenue guidance to $3.49–$3.502 billion. Shares were down 4.02% after hours to $48.85.

$DOCUMedAI 9/10

DocuSign (DOCU) Q1 Earnings Report Preview: What To Look For

DocuSign will report Q1 results Thursday after the bell, according to the article. The company’s prior quarter revenue was $836.9 million (+7.8% YoY), but it missed annual recurring revenue estimates. For Q1, analysts expect revenue +8.1% YoY. The article cites an average analyst price target of $59.88 vs. $55.18.